Latest filing published 29 Sept 2016 for Radius Health, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
MPM Bioventures III LLC: trading record in brief
This profile gathers the share dealings of MPM Bioventures III LLC across 5 companies, led by EPIRUS Biopharmaceuticals, Inc., Altimmune, Inc. and Radius Health, Inc. Over a trading history stretching from 27 April 2007 to 27 September 2016, the count stands at 40 filings.
Both buying and selling appear: 4 purchases worth €6.7M, against 26 sales worth €15.8M. On balance, insiders were net sellers of €9.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €885k.
On 29 September 2016 came the latest disclosure, a transaction in Radius Health, Inc. The clock since the last published purchase (5 November 2010) now reads 5,848 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to MPM Bioventures III LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,229,902 shares0Common StockSEC:0001209191-16-143184:0
- 1,294,134 sharesCommon StockSEC:0001209191-14-040347:0
- 1,045,351 sharesCommon StockSEC:0001209191-14-040347:1
- 255,881 sharesCommon StockSEC:0001209191-14-040347:2
- 399,891 sharesCommon StockSEC:0001209191-14-040347:3
- 694,449 sharesCommon StockSEC:0001209191-14-040347:4
- 738,807 shares@ US$1.03Common StockSEC:0001209191-11-053080:0
- 34,817 shares@ US$1.02Common StockSEC:0001209191-11-052367:0
- 425,000 shares@ US$1.03Common StockSEC:0001209191-11-052367:1
- 5,000 shares@ US$1.02Common StockSEC:0001209191-11-051842:0
- 39,700 shares@ US$1.02Common StockSEC:0001209191-11-051842:1
- 210,000 shares@ US$1.11Common StockSEC:0001209191-11-049251:0
- 200,000 shares@ US$1.09Common StockSEC:0001209191-11-049251:1
- 2,428,171 shares@ US$2.5417Common StockSEC:0001209191-10-053401:0
- 430,000 shares@ US$3.50Common StockSEC:0001209191-10-053401:1Canonical exit: 1 Feb 2011 (T+90)
- 7,913,653 sharesCommon StockSEC:0001209191-10-000401:0
- 78,262 shares@ US$8.0025Common StockSEC:0001209191-09-051752:0
- 264,648 shares@ US$8.0581Common StockSEC:0001209191-09-051752:1
- 152,052 shares@ US$8.50Common StockSEC:0001209191-09-051752:2
- 3,239,443 sharesCommon StockSEC:0001209191-07-056843:0
- 3,218,250 sharesCommon StockSEC:0001209191-07-046690:0
- 125,000 shares@ US$7.70Common StockSEC:0001209191-07-046690:1Canonical exit: 5 Nov 2007 (T+90)
- 43,100 shares@ US$18.0691Common StockSEC:0001209191-07-026589:0
- 19,500 shares@ US$18.0626Common StockSEC:0001209191-07-026589:1
24 of 24 declarations
